Gesynta Pharma has completed recruitment for its Phase 2 trial [...]

Oncodesign Services and Nexus BioQuest have formed a preclinical research [...]

Medicus Pharma has received authorisation from the UAE Department of [...]

Absci has reported positive interim Phase 1 data for ABS-201, [...]

Gesynta Pharma has randomised half of the planned patients in [...]

Medicus Pharma has submitted an investigational new drug application in [...]

Women’s health remains underfunded, underdiagnosed and undervalued — but a [...]

Gesynta Pharma has announced the second closing of its Series [...]

Dr Anita Phung, GP and medical monitor at Lindus Health, [...]